thoracic radiotherapy (TRT)

RADIATION2 trials

Sponsors

Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest, Jiangmen Central Hospital

Conditions

Lung Cancer (NSCLC)Malignant Pleural Effusions (Mpe)- PleurodesisSmall Cell Lung Cancer Extensive StageThoracic Radiotherapy

Phase 2

Thoracic RadiothErapy With Atezolizumab in Small Cell lUng canceR Extensive Disease

CompletedNCT04462276

Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus NordwestSmall Cell Lung Cancer Extensive Stage, Thoracic Radiotherapy

Start: 2020-07-28End: 2024-09-02Updated: 2025-01-30

Furmonertinib Plus Radiotherapy for EGFR+ NSCLC With Pleural Effusion

Not yet recruitingNCT07482605

Jiangmen Central HospitalLung Cancer (NSCLC), Malignant Pleural Effusions (Mpe)- Pleurodesis

Start: 2026-07-01End: 2028-01-01Target: 63Updated: 2026-07-17

Related Papers

Consolidative Thoracic Radiotherapy With Atezolizumab Maintenance in Extensive-Stage Small Cell Lung Cancer: The Phase 2 TREASURE Randomized Clinical Trial (AIO-TRK-0320).

2026-07-09

Protocol of the TREASURE study: Thoracic RadiothErapy with Atezolizumab in Small cell lUng canceR Extensive disease - a randomized, open-label, multicenter phase II trial.

2022-09-2414 citations